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Figure 2. Sulfonyl Fluorides Bind to Tyrosine Functional Hot Spots
(A) An overlay of a crystal structure and homology models of GSTs from four different classes. Despite the
low sequence identity, the 3D structures have a good overlap.
(B) A close-up view of the tyrosine residues labeled by the SF probe (Y208, red; Y116, green; Y228, blue;
Y108, orange). All tyrosines are in close proximity to the xenobiotic binding site (H-site) and further away
from the glutathione binding site (G-site).
(C) A close-up view of the active site of DPPIV, with AEBSF bound to Y547 (both in red). The catalytic triad
S630, H740, and D708 are depicted in yellow (Protein Data Bank ID code 2AJC).
Chemistry & Biology
Previewsthe mutant displayed a severely reduced
catalytic efficiency, demonstrating the
functional importance of this tyrosine res-
idue. Overall, the results by Gu et al.
(2013) highlight that SFs are suitable RPs
that can be used to reveal tyrosine resi-
dues as functional hot spots in proteins.
As mentioned, the basic structure of
RPs developed by Gu et al. (2013) is
AEBSF (Figure 1C), a commonly used
serine protease inhibitor also marketed
as Pefabloc. As described here and else-458 Chemistry & Biology 20, April 18, 2013 ªwhere, its reactivity is not restricted to
serine residues. This was observed even
in the case of serine proteases them-
selves, as illustrated by a crystal structure
of the serine protease DPPIV in complex
with AEBSF. In this complex, the SF can
also be seen bound to a tyrosine residue
(Engel et al., 2006). Interestingly, the
particular tyrosine is part of the oxyanion
hole, and hence, also represents a func-
tional hot spot (Figure 2C). Evidently, the
usage of AEBSF as a selective inhibitor2013 Elsevier Ltd All rights reservedfor serine proteases should be discour-
aged, but the molecule has gained a func-
tion as a scaffold for RPs. Since Gu et al.
(2013) identify tyrosines in many more
proteins besides GSTs, the sulfonyl fluo-
ride probes hold great promise for the
future identification of functional tyrosines
in other protein families.
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In this issue of Chemistry & Biology, Renicke et al. report a photosensitive degron (psd) consisting of the
LOV2 domain fused to a protein degradation sequence. This design enabled light-dependent protein degra-
dation in yeast. When psd was fused to cell-cycle-dependent proteins, it controlled cell cycle by light with
spatiotemporal precision.The development of real-time, protein-
based tools to control cellular functions
promises everything from new assays forbasic research to gadgets to be built into
sophisticated synthetic biomachines.
Recent reports have highlighted tools totarget key nodes in protein networks regu-
lating gene expression (Levskaya et al.,
2005; Strickland et al., 2008, 2010), cell
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Figure 1. Schematic of LOV2-basedChimeras for Control of Cellular
Functions
(A) Generalized schematic of existing chimeras to control the genetic ele-
ments, cell morphology regulators, a natively ER-localized Ca2+ sensor and
a constitutively active caspase.
(B) Themodular approach of Renicke et al. (2013) to LOV2-based regulation of
cellular proteins by ‘‘inhibition’’ through degradation of a suite of target pro-
teins, aligned with the generalized schematic of other LOV2-based regulators
depicted in (A).
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Previewsmorphology and migration
(Levskaya et al., 2009; Wu
et al., 2009), Ca2+ signaling
(Pham et al., 2011), and
apoptosis (Gray et al., 2010;
Mills et al., 2012). A typical
design strategy has emerged
based on the fusion of a
sensory domain with an
effector domain to create a
chimera where internal allo-
stery, binding or some other
control mechanism yield con-
trol over the effector by the
sensor. By extension, the
chimera transforms the sen-
sor’s input signal into the ef-
fector’s output effect with
some level of spatiotemporal
control.
One of the most attractive
input signals has been light
due to the relative ease with
which light can be controlled
and delivered in experimental
settings. A number of reports
have described the develop-
ment of such light-based, or
optogenetic, chimeras that
incorporate the LOV2 domain
from A. thaliana phototropin1
as the sensory domain
(Harper et al., 2003), trans-forming blue light into some kind of output
effect (Figure 1A); examples have
included control over genetic regulation
via the trp repressor(Strickland et al.,
2008), cell morphology and migration via
Rac1 and Cdc42 (Wu et al., 2009), Ca2+
influx via Stim1 (Pham et al., 2011), and
cell death via caspase-7 (Mills et al.,
2012). Now, Renicke et al. (2013), report
the fusion of a synthetic degron from
murine ornithine decarboxylase (cODC1)
with LOV2 that results in blue light-depen-
dent photoswitchable protein degrada-
tion (Renicke et al., 2013). The chimera,
a photosensitive degron (psd), appears
to satisfy the ‘‘usual’’ control experiments
for LOV2-based chimeras including
Cys/Ala mutation of the flavin mononu-
cleotide binding pocket of LOV2 inhibition
of light sensitivity, wavelength-depen-
dency, and thermal reversibility. Impor-
tantly, the authors demonstrate that their
psd can be further fused with a range of
target proteins to regulate their degrada-
tion (Figure 1B), thereby yielding optoge-
netic regulators of the cell cycle, secretionand biochemical synthesis, and poten-
tially many other physiologically relevant
functions. Several of the experimental ob-
servations (e.g., rate of fluorescence in-
tensity reduction of an RFP-tagged psd
exposed to blue light) were in fairly close
agreement with a deterministic model of
the synthesis, activation, and degration
of psd developed as part of the report.
The report of psd is a notable addition
to the existing array of LOV2-based pro-
tein tools for at least three reasons. First,
the report adds to the trend confirming
the general approach to designing
LOV2-based chimeras through ‘‘rational
trial-and-error’’ by experimenting with
linker lengths (Wu et al., 2009) and trunca-
tion mutants (Pham et al., 2011). Second,
while previously reported optogenetic
tools have focused on regulating the intra-
cellular concentration of effector proteins
through manipulating synthesis (Lev-
skaya et al., 2005), or the conformational
or chemical state of already synthesized
proteins (Strickland et al., 2008; Levskaya
et al., 2009; Wu et al., 2009, Pham et al.,Chemistry & Biology 20, April 18, 2013 ª2013 Else2011; Mills et al., 2012), the
current report manipulates
degradation rates. Third, and
perhaps most importantly,
psd represents a potentially
generalizable modular ap-
proach that could allow
LOV2-based control over a
wide variety of target protein
effectors without requiring
time consuming re-designs
of linkers between the car-
boxy-terminus of LOV2 and
its Ja helix and the target
protein. Provided that the
psd design is as robust as
this initial report appears,
this approach could result in
a powerful tool for regulating
a wide array of cellular
functions.
Immediate future work
for psd will hopefully verify
that the observations in
S. cerevisiae and predictions
in silico can be extended to
metazoan (i.e., mammalian
and especially human) cells,
as the authors hypothesized
given the evolutionarily con-
served mechanism of degra-
dation of cODC1. Should psd
prove to provide LOV2-basedregulation over biosynthesis, secretion
and cell cycle progression in mammalian
cells, psd could allow more precise con-
trol over patterning and development of
engineered tissue constructs than is
currently available with other approaches
such as microfluidics or growth-factor
deposition whose spatial precision are
generally limited by diffusion or convec-
tion. The potential for psd as a tool for
high-throughput research of drugs or
drug targets for, say, cell cycle regulation,
should not be understated.
Longer-term improvements to psd
could address more subtle challenges.
For example, the apparent reversibility of
psd (i.e., protein concentration begins to
rebound within an hour in the dark) is
consistent with the notion of LOV2-based
reversibility through thermal relaxation.
However, the lack of memory implies that
the input blue light signal must always be
‘‘on’’ to produce an output effect, which
may not be desirable while developing
more complex applications of psd such
as the tissue engineering suggestedvier Ltd All rights reserved 459
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Previewsabove and by the authors. The relatively
long half-time needed to observe degra-
dation of the RFP-tagged psd may also
represent a potential limitation of the
tool. The authors’ deterministic in silico
model could prove a useful aid in address-
ing some of these challenges. For
example, the authors determined with
the help of their model that reducing
the ‘‘leak’’ rate of LOV2, or the rate of lit
state conversion of psd in the dark, could
increase the dynamic range of target pro-
tein activity between light and dark states.
This may lead to a chimera that switches
states more quickly or leads to more stark
phenotypic changes; previously reported
LOV2 mutations could provide a way to460 Chemistry & Biology 20, April 18, 2013 ªrealize this improvement. Regardless of
future improvements and applications,
psd represents a notable addition to the
growing suite of LOV2-based optogenetic
tools.
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